VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 385 filers reported holding VANECK VECTORS ETF TR in Q4 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $480,000 | -14.7% | 12,259 | -20.1% | 0.25% | -17.7% |
Q2 2020 | $563,000 | +3027.8% | 15,339 | +1834.3% | 0.30% | +4171.4% |
Q2 2018 | $18,000 | -80.0% | 793 | -80.7% | 0.01% | -73.1% |
Q1 2018 | $90,000 | +4.7% | 4,103 | +10.8% | 0.03% | +4.0% |
Q4 2017 | $86,000 | +22.9% | 3,703 | +21.4% | 0.02% | +4.2% |
Q3 2017 | $70,000 | +311.8% | 3,050 | +286.1% | 0.02% | +300.0% |
Q2 2017 | $17,000 | – | 790 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |